Quest Reports 1 Percent Q4 Sales Dip | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics today reported that its fourth quarter sales were down around 1 percent year over year.

The clinical lab and diagnostic information services provider reported revenues of $1.76 billion for the three months ended Dec. 31, 2013, down one percent year over year from $1.77 billion. Analysts, on average, had estimated the firm's revenue for the quarter at around $1.74 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.